Business Description
ACI Formulations Ltd
ISIN : BD0480ACIFL4
Description
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.92 | |||||
| Debt-to-EBITDA | 4.48 | |||||
| Interest Coverage | 1.87 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.25 | |||||
| Beneish M-Score | -2.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.1 | |||||
| 3-Year EBITDA Growth Rate | 14.1 | |||||
| 3-Year EPS without NRI Growth Rate | 36.3 | |||||
| 3-Year Book Growth Rate | 8.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.89 | |||||
| 9-Day RSI | 26.86 | |||||
| 14-Day RSI | 29.95 | |||||
| 6-1 Month Momentum % | -16.06 | |||||
| 12-1 Month Momentum % | -20.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.23 | |||||
| Quick Ratio | 0.93 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 161.54 | |||||
| Days Sales Outstanding | 101.95 | |||||
| Days Payable | 16.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.03 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| 3-Year Dividend Growth Rate | -9.1 | |||||
| Forward Dividend Yield % | 2.03 | |||||
| 5-Year Yield-on-Cost % | 2.67 | |||||
| Shareholder Yield % | 2.51 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.94 | |||||
| Operating Margin % | 10.76 | |||||
| Net Margin % | 4.94 | |||||
| FCF Margin % | 3.73 | |||||
| ROE % | 7.92 | |||||
| ROA % | 3.5 | |||||
| ROIC % | 6.62 | |||||
| ROC (Joel Greenblatt) % | 11.78 | |||||
| ROCE % | 18.39 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.3 | |||||
| PE Ratio without NRI | 23.3 | |||||
| Shiller PE Ratio | 23.72 | |||||
| Price-to-Owner-Earnings | 23.58 | |||||
| PEG Ratio | 3.64 | |||||
| PS Ratio | 1.15 | |||||
| PB Ratio | 1.85 | |||||
| Price-to-Tangible-Book | 1.86 | |||||
| Price-to-Free-Cash-Flow | 30.88 | |||||
| Price-to-Operating-Cash-Flow | 17.85 | |||||
| EV-to-EBIT | 13.68 | |||||
| EV-to-EBITDA | 13.21 | |||||
| EV-to-Revenue | 1.68 | |||||
| EV-to-FCF | 45.05 | |||||
| Price-to-Projected-FCF | 2.12 | |||||
| Price-to-DCF (Earnings Based) | 2.02 | |||||
| Price-to-DCF (FCF Based) | 2.68 | |||||
| Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.13 | |||||
| Price-to-Graham-Number | 1.39 | |||||
| Price-to-Net-Current-Asset-Value | 10.37 | |||||
| Earnings Yield (Greenblatt) % | 7.31 | |||||
| FCF Yield % | 3.24 | |||||
| Forward Rate of Return (Yacktman) % | 8.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ACI Formulations Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 5,049.461 | ||
| EPS (TTM) (BDT) | 5.278 | ||
| Beta | 0 | ||
| Volatility % | 11.6 | ||
| 14-Day RSI | 29.95 | ||
| 14-Day ATR (BDT) | 2.775471 | ||
| 20-Day SMA (BDT) | 126.7 | ||
| 12-1 Month Momentum % | -20.57 | ||
| 52-Week Range (BDT) | 122.6 - 172 | ||
| Shares Outstanding (Mil) | 47.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ACI Formulations Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ACI Formulations Ltd Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
ACI Formulations Ltd Frequently Asked Questions
What is ACI Formulations Ltd(DHA:ACIFORMULA)'s stock price today?
The current price of DHA:ACIFORMULA is BDT123.00. The 52 week high of DHA:ACIFORMULA is BDT172.00 and 52 week low is BDT122.60.
When is next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA)?
The next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA) is .
Does ACI Formulations Ltd(DHA:ACIFORMULA) pay dividends? If so, how much?
The Dividend Yield %  of ACI Formulations Ltd(DHA:ACIFORMULA) is 2.03% (As of Today), Highest Dividend Payout Ratio of ACI Formulations Ltd(DHA:ACIFORMULA) was 1.7. The lowest was 0.34. And the median was 0.58. The  Forward Dividend Yield % of ACI Formulations Ltd(DHA:ACIFORMULA) is 2.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers